These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16224052)

  • 1. Mechanisms of increased vascular superoxide production in an experimental model of idiopathic dilated cardiomyopathy.
    Mollnau H; Oelze M; August M; Wendt M; Daiber A; Schulz E; Baldus S; Kleschyov AL; Materne A; Wenzel P; Hink U; Nickenig G; Fleming I; Münzel T
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2554-9. PubMed ID: 16224052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
    Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
    Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice.
    Oelze M; Warnholtz A; Faulhaber J; Wenzel P; Kleschyov AL; Coldewey M; Hink U; Pongs O; Fleming I; Wassmann S; Meinertz T; Ehmke H; Daiber A; Münzel T
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1753-9. PubMed ID: 16763163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanylyl cyclase activator ataciguat improves vascular function and reduces platelet activation in heart failure.
    Schäfer A; Fraccarollo D; Werner L; Bauersachs J
    Pharmacol Res; 2010 Nov; 62(5):432-8. PubMed ID: 20600916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.
    Mollnau H; Schulz E; Daiber A; Baldus S; Oelze M; August M; Wendt M; Walter U; Geiger C; Agrawal R; Kleschyov AL; Meinertz T; Münzel T
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):615-21. PubMed ID: 12692005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4.
    Wendt MC; Daiber A; Kleschyov AL; Mülsch A; Sydow K; Schulz E; Chen K; Keaney JF; Lassègue B; Walter U; Griendling KK; Münzel T
    Free Radic Biol Med; 2005 Aug; 39(3):381-91. PubMed ID: 15993337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase.
    Münzel T; Daiber A; Ullrich V; Mülsch A
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1551-7. PubMed ID: 15879305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.
    Oelze M; Daiber A; Brandes RP; Hortmann M; Wenzel P; Hink U; Schulz E; Mollnau H; von Sandersleben A; Kleschyov AL; Mülsch A; Li H; Förstermann U; Münzel T
    Hypertension; 2006 Oct; 48(4):677-84. PubMed ID: 16940222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension.
    Schulz E; Jansen T; Wenzel P; Daiber A; Münzel T
    Antioxid Redox Signal; 2008 Jun; 10(6):1115-26. PubMed ID: 18321209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system.
    Ungvari Z; Csiszar A; Kaminski PM; Wolin MS; Koller A
    Am J Pathol; 2004 Jul; 165(1):219-26. PubMed ID: 15215177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NO and PGI(2) in coronary endothelial dysfunction in transgenic mice with dilated cardiomyopathy.
    Drelicharz L; Kozlovski V; Skorka T; Heinze-Paluchowska S; Jasinski A; Gebska A; Guzik T; Olszanecki R; Wojnar L; Mende U; Csanyi G; Chlopicki S
    Basic Res Cardiol; 2008 Sep; 103(5):417-30. PubMed ID: 18431525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-dependent vascular alterations in young cardiomyopathic hamsters: role for oxidative stress.
    Escobales N; Crespo MJ
    Vascul Pharmacol; 2006 Jan; 44(1):22-8. PubMed ID: 16301003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
    Onozato ML; Tojo A; Goto A; Fujita T; Wilcox CS
    Kidney Int; 2002 Jan; 61(1):186-94. PubMed ID: 11786100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent.
    Widder J; Behr T; Fraccarollo D; Hu K; Galuppo P; Tas P; Angermann CE; Ertl G; Bauersachs J
    Cardiovasc Res; 2004 Jul; 63(1):161-7. PubMed ID: 15194473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression.
    Bauersachs J; Heck M; Fraccarollo D; Hildemann SK; Ertl G; Wehling M; Christ M
    J Am Coll Cardiol; 2002 Jan; 39(2):351-8. PubMed ID: 11788231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice.
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1093-102. PubMed ID: 17596536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet nitric oxide signalling in heart failure: role of oxidative stress.
    Shah A; Passacquale G; Gkaliagkousi E; Ritter J; Ferro A
    Cardiovasc Res; 2011 Sep; 91(4):625-31. PubMed ID: 21502370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition.
    Schäfer A; Fraccarollo D; Hildemann S; Christ M; Eigenthaler M; Kobsar A; Walter U; Bauersachs J
    Thromb Haemost; 2003 Jun; 89(6):1024-30. PubMed ID: 12783115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.